Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis

Jing Chen, Bruce Taylor, Tania Winzenberg, Andrew J. Palmer, Andrea Kirk-Brown, Pieter van Dijk, Steve Simpson, Leigh Blizzard, Ingrid van der Mei

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: More work is needed to understand the burden of comorbidities in people with multiple sclerosis (MS). Objective: To assess prevalence of 30 comorbidities and impacts of comorbidities on employment outcomes in a working-aged MS cohort. Methods: Participants were from the Australian MS Longitudinal Study (n = 929). Information on specific comorbidity was obtained (whether or not each was present, doctor-diagnosed, limited their activities and being treated). Results: Comorbidities most frequently reported to limit activities were osteoarthritis (51%), migraines (40%), anxiety (33%), depression (29%) and allergies (18%). Mean MS-related work productivity loss in past 4 weeks was 1.3 days for those without comorbidities and 2.5 days for those with any comorbidity. The annual population costs of work productivity loss were highest for people with depression, allergies, anxiety, migraines and osteoarthritis. Higher number of comorbidities was associated with more work productivity loss and a higher likelihood of not working. These associations were substantially reduced after adjustment for MS symptom severity. Conclusions: Comorbidities substantially impact employment outcomes and these effects were mainly mediated through MS symptom severity. This suggests that optimal and simultaneous management of comorbidities may be a viable strategy to reduce MS symptom severity, which in turn could improve employment outcomes.

Original languageEnglish
Number of pages10
JournalMultiple Sclerosis Journal
DOIs
Publication statusAccepted/In press - 2019

Keywords

  • comorbidity
  • depression
  • employment
  • Multiple sclerosis
  • symptom
  • work productivity

Cite this

Chen, Jing ; Taylor, Bruce ; Winzenberg, Tania ; Palmer, Andrew J. ; Kirk-Brown, Andrea ; van Dijk, Pieter ; Simpson, Steve ; Blizzard, Leigh ; van der Mei, Ingrid. / Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis. In: Multiple Sclerosis Journal. 2019.
@article{c440777a085342e78725751a9463c6ef,
title = "Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis",
abstract = "Background: More work is needed to understand the burden of comorbidities in people with multiple sclerosis (MS). Objective: To assess prevalence of 30 comorbidities and impacts of comorbidities on employment outcomes in a working-aged MS cohort. Methods: Participants were from the Australian MS Longitudinal Study (n = 929). Information on specific comorbidity was obtained (whether or not each was present, doctor-diagnosed, limited their activities and being treated). Results: Comorbidities most frequently reported to limit activities were osteoarthritis (51{\%}), migraines (40{\%}), anxiety (33{\%}), depression (29{\%}) and allergies (18{\%}). Mean MS-related work productivity loss in past 4 weeks was 1.3 days for those without comorbidities and 2.5 days for those with any comorbidity. The annual population costs of work productivity loss were highest for people with depression, allergies, anxiety, migraines and osteoarthritis. Higher number of comorbidities was associated with more work productivity loss and a higher likelihood of not working. These associations were substantially reduced after adjustment for MS symptom severity. Conclusions: Comorbidities substantially impact employment outcomes and these effects were mainly mediated through MS symptom severity. This suggests that optimal and simultaneous management of comorbidities may be a viable strategy to reduce MS symptom severity, which in turn could improve employment outcomes.",
keywords = "comorbidity, depression, employment, Multiple sclerosis, symptom, work productivity",
author = "Jing Chen and Bruce Taylor and Tania Winzenberg and Palmer, {Andrew J.} and Andrea Kirk-Brown and {van Dijk}, Pieter and Steve Simpson and Leigh Blizzard and {van der Mei}, Ingrid",
year = "2019",
doi = "10.1177/1352458519872644",
language = "English",
journal = "Multiple Sclerosis Journal",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",

}

Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis. / Chen, Jing; Taylor, Bruce; Winzenberg, Tania; Palmer, Andrew J.; Kirk-Brown, Andrea; van Dijk, Pieter; Simpson, Steve; Blizzard, Leigh; van der Mei, Ingrid.

In: Multiple Sclerosis Journal, 2019.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Comorbidities are prevalent and detrimental for employment outcomes in people of working age with multiple sclerosis

AU - Chen, Jing

AU - Taylor, Bruce

AU - Winzenberg, Tania

AU - Palmer, Andrew J.

AU - Kirk-Brown, Andrea

AU - van Dijk, Pieter

AU - Simpson, Steve

AU - Blizzard, Leigh

AU - van der Mei, Ingrid

PY - 2019

Y1 - 2019

N2 - Background: More work is needed to understand the burden of comorbidities in people with multiple sclerosis (MS). Objective: To assess prevalence of 30 comorbidities and impacts of comorbidities on employment outcomes in a working-aged MS cohort. Methods: Participants were from the Australian MS Longitudinal Study (n = 929). Information on specific comorbidity was obtained (whether or not each was present, doctor-diagnosed, limited their activities and being treated). Results: Comorbidities most frequently reported to limit activities were osteoarthritis (51%), migraines (40%), anxiety (33%), depression (29%) and allergies (18%). Mean MS-related work productivity loss in past 4 weeks was 1.3 days for those without comorbidities and 2.5 days for those with any comorbidity. The annual population costs of work productivity loss were highest for people with depression, allergies, anxiety, migraines and osteoarthritis. Higher number of comorbidities was associated with more work productivity loss and a higher likelihood of not working. These associations were substantially reduced after adjustment for MS symptom severity. Conclusions: Comorbidities substantially impact employment outcomes and these effects were mainly mediated through MS symptom severity. This suggests that optimal and simultaneous management of comorbidities may be a viable strategy to reduce MS symptom severity, which in turn could improve employment outcomes.

AB - Background: More work is needed to understand the burden of comorbidities in people with multiple sclerosis (MS). Objective: To assess prevalence of 30 comorbidities and impacts of comorbidities on employment outcomes in a working-aged MS cohort. Methods: Participants were from the Australian MS Longitudinal Study (n = 929). Information on specific comorbidity was obtained (whether or not each was present, doctor-diagnosed, limited their activities and being treated). Results: Comorbidities most frequently reported to limit activities were osteoarthritis (51%), migraines (40%), anxiety (33%), depression (29%) and allergies (18%). Mean MS-related work productivity loss in past 4 weeks was 1.3 days for those without comorbidities and 2.5 days for those with any comorbidity. The annual population costs of work productivity loss were highest for people with depression, allergies, anxiety, migraines and osteoarthritis. Higher number of comorbidities was associated with more work productivity loss and a higher likelihood of not working. These associations were substantially reduced after adjustment for MS symptom severity. Conclusions: Comorbidities substantially impact employment outcomes and these effects were mainly mediated through MS symptom severity. This suggests that optimal and simultaneous management of comorbidities may be a viable strategy to reduce MS symptom severity, which in turn could improve employment outcomes.

KW - comorbidity

KW - depression

KW - employment

KW - Multiple sclerosis

KW - symptom

KW - work productivity

UR - http://www.scopus.com/inward/record.url?scp=85073773528&partnerID=8YFLogxK

U2 - 10.1177/1352458519872644

DO - 10.1177/1352458519872644

M3 - Article

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

SN - 1352-4585

ER -